Ask HopeStage to review this study with me
Study ID: NCT05191277. We help you review the study, but cannot decide medical eligibility.
CompletedNCT05191277
Disentangling Pharmacological and Expectation Effects in Antidepressant Discontinuation
This study is completed. It focuses on depression and currently lists study information in Germany.
Depression, ExpectationsBehavioralFrom 18 Years to 75 Years
Key information made simple
What is this study testing?
This study is testing whether a therapy or guided support program may be useful for adults experiencing depression.
What would participation involve?
Participants may take part in a therapy or guided support program, complete questionnaires or follow-up assessments, attend study visits with the research team. The registry lists locations in Germany.
Who is it mainly for?
This study appears to be mainly for adults with depression.
What should you check before joining?
Ask about how many sessions are required and who delivers them, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
The official record does not clearly describe the visit format, so the practical details are best checked directly in the source. Participation appears to involve study activities and follow-up chosen by the research team. The main fit and exclusions are best confirmed in the eligibility section of the official record. The phase details are not clearly stated here.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateStarted: August 1, 2022
- Recruitment status
- Completed
- Estimated enrollment
- Not clearly listed
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Sponsor type
- Unknown or unclear
- Study type
- Behavioral
- Intervention type
- Behavioral / psychological / psychosocial
- Study phase
- Not clearly listed
- Locations
- Germany
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT05191277
- Official title
- Disentangling Pharmacological and Expectation Effects in Antidepressant Discontinuation
- Official source
- Official registry link
Want help reviewing this study?
Study ID: NCT05191277. We help you review the study, but cannot decide medical eligibility.
For you
Taking part may help test a support approach in real life.
It requires regular follow-up, often through questionnaires or interviews.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring psychotherapy or therapy for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
What is a behavioral study?
This appears to be a behavioral / psychological / psychosocial study. Phase is mainly useful to check for medication studies and some device studies.
Who might this study be for?
This study may concern people with depression; age range: From 18 Years to 75 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may take part in sessions or exercises related to habits, thoughts, emotions, or behaviors. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
Will I need to change, stop, or stabilize my current treatment?
The public registry appears to mention rules about current treatment, stability, stopping treatment, or dose changes. Do not change your treatment for a study without medical guidance. Ask the study team and your clinician what is required, what is not allowed, and how safety is monitored.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Universitätsklinikum Hamburg-Eppendorf, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The registry indicates that this study is completed. It may still be useful for understanding the research, but you are unlikely to be able to join.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedNCT07100548
A Qualitative Analysis of Youth Responses to Depression Education Delivered on Social Media
This study is completed. It focuses on depression and currently lists study information in Germany.
CompletedNCT00914680
Berlin Magnetic Seizure Therapy Depression study 01
This study is completed. It focuses on depression and currently lists study information in Germany.
CompletedNCT07061600
Enhancing Depression Literacy and Reducing Stigma in Adolescents Through Social Media
This study is completed. It focuses on depression and currently lists study information in Germany.